Ultimate Sidebar

Personalizing and Targeting Therapy for COPD

109 16
Personalizing and Targeting Therapy for COPD

Other Comorbidities


Other important comorbidities should be factored into the assessment and management of patients with COPD, including nutritional and musculoskeletal issues (e.g., being overweight or underweight; osteoporosis; peripheral muscle weakness); and psychosocial conditions (e.g., anxiety and depression). Of importance, peripheral skeletal muscle weakness leads to impaired exercise tolerance, not only in older, frail patients but also in less advanced COPD. Assessment of nutritional and metabolic biomarkers is clinically relevant in COPD, since distinct body composition profiles have been identified in COPD that relate to reduced physical functioning, increased osteoporosis risk and also increased cardiometabolic risk. Addressing nutritional and exercise goals, based on relevant metabolic biomarkers, would improve systemic aspects of COPD and improve quality of life for patients.

Source: ...
Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.